Gregory Adams, MD
Urology · Kalispell, MTNPI 1366659476
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $456 of the $669 with a category attached, or 68.1%. 9 manufacturers reported payments, led by Astellas Pharma US Inc at 47.8% of the total. Reporting peaked in 2019 at $304 and has fallen 80.5% since, to $59 in 2025. That places this record below the midpoint for urology clinicians in MT, where the typical reported total is $1,996.
Across 29 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$320
- Boston Scientific$168
- Procept Biorobotics Corporation$45
- Dendreon Pharmaceuticals LLC$41
- AbbVie$28
- Pfizer$28
- plus $38 from 3 others
What the payments were for
- Food & beverage$45668%
- Education$21332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $320 |
| Boston Scientific | 7 | $168 |
| Procept Biorobotics Corporation | 1 | $45 |
| Dendreon Pharmaceuticals LLC | 2 | $41 |
| AbbVie | 2 | $28 |
| Pfizer | 2 | $28 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Travere Therapeutics, Inc. | 3 | $11 |
How this compares
$669 in reported general payments places this provider in the 20th percentile of 45 urology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 56 | $34,525 |
| GemtesaVibegron | 17 | $13,351 |
| Solifenacin Succinate | 118 | $10,123 |
| Tamsulosin Hcl | 477 | $6,451 |
| Potassium Citrate ErPotassium Citrate | 29 | $6,101 |
| Finasteride | 302 | $4,274 |
| Tolterodine Tartrate ErTolterodine Tartrate | 17 | $2,779 |
| Testosterone Cypionate | 35 | $1,622 |
| Cephalexin | 81 | $1,217 |
| Oxybutynin Chloride | 124 | $1,055 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 11 | $852 |
| Bicalutamide | 35 | $736 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 39 | $714 |
| Levofloxacin | 100 | $449 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $390 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $320 | $34,52556 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 45 urology providers in Montana.
Other urology in Kalispell
- Amy McKerrowKalispell$9K
- Sarabeth MartinKalispell$4K
- John AndenoroKalispell$3K
- Geraldine SheuKalispell$2K
- Jonathan MercerKalispell$2K
- Vassilis SiomosKalispell$2K
- Michael BersonKalispell$95
- Craig HinmanKalispell$29
- Christopher FukudaGreat Falls$19K
- Garrick SimmonsMissoula$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.